103008 <common-name>2,2'-[[1,1'-Biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutyramide]</common-name> <description>2,2'-[[1,1'-Biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutyramide] belongs to the biphenyls and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. It is classified as a benzenoid with the formula C32H26Cl2N6O4. With an average molecular weight of 629.50 g/mol, 2,2'-[[1,1'-Biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutyramide] is a heavy molecule.</description> <cas>94249-03-3</cas> <pubchem-id>57356734</pubchem-id> <chemical-formula>C32H26Cl2N6O4</chemical-formula> <weight>629.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-05T10:12:00Z</created-at> <updated-at type="dateTime">2026-08-31T18:04:26Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)C(N=NC1=CC=C(C=C1)C1=CC=C(C=C1)N=NC(C(C)=O)C(=O)NC1=CC=C(Cl)C=C1)C(=O)NC1=CC=C(Cl)C=C1</moldb-smiles> <moldb-formula>C32H26Cl2N6O4</moldb-formula> <moldb-inchi>InChI=1/C32H26Cl2N6O4/c1-19(41)29(31(43)35-25-15-7-23(33)8-16-25)39-37-27-11-3-21(4-12-27)22-5-13-28(14-6-22)38-40-30(20(2)42)32(44)36-26-17-9-24(34)10-18-26/h3-18,29-30H,1-2H3,(H,35,43)(H,36,44)</moldb-inchi> <moldb-inchikey>UPSAJZSSQKUOAT-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal">629.5</moldb-average-mass> <moldb-mono-mass type="decimal">628.1392587</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>8.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM098901</chemdb-id> <dsstox-id>DTXSID90915876</dsstox-id> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id>NS00066559</susdat-id> <iupac>2-[[4-[4-[[1-(4-chloroanilino)-1,3-dioxobutan-2-yl]diazenyl]phenyl]phenyl]diazenyl]-N-(4-chlorophenyl)-3-oxobutanamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Biphenyls and derivatives</subklass> <paper-count type="integer">0</paper-count> <sync-id>CED0116938</sync-id> <structure-inchikey>UPSAJZSSQKUOAT-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000000000000000000024000000000000100200080000000000000000000000000000000000000000000001000000000000000000000000000000000000000400400000000000000000020000000000000000004000000000000000000010080000010000000000000800000001000000000000000000000400000000040020400000000000000000080800000000000000000000000000000000000002100000000000000080000000000000000000000000000000000000000000000000100000000000100000000800010000200000000000200000000000000008000000002000040800000000400000000000800000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAALwAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCBgBgAAAAAwEHACgAAAADAwcAKAAAAAMDBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEHACgAAAADAwcAKAAAAAMDBgBgAAAAAwEGACgAAAADBAYAYAAAAAEDCAAo AAAAAwIGACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAAD AwEGQGgAAAADAwEGQCgAAAADBBEAIAAAAAEGQGgAAAADAwEGQGgAAAADAwEG ACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQGgA AAADAwEGQCgAAAADBBEAIAAAAAEGQGgAAAADAwEGQGgAAAADAwELAAEAAQII AgEDAAMEAAQFKAIFBiAGB2gMBwhoDAgJaAwJCmgMCgtoDAkMIAwNaAwNDmgM Dg9oDA8QaAwQEWgMDxIgEhMoAhMUABQVABUWABUXCAIUGAAYGSgCGBogGhsg GxxoDBwdaAwdHmgMHh8AHiBoDCAhaAwDIgAiIygCIiQgJCUgJSZoDCYnaAwn KGgMKCkAKCpoDCoraAwLBmgMEQxoDCEbaAwrJWgMQgQAAAAGBwgJCgsGBg0O DxARDAYcHR4gIRsGJicoKislFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:40:45Z</structure-indexed-at> </compound>